Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3467)
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
3,000
Price
$3.73
Total Value
$11.19K
Shares Held After
643,812
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
113
Price
$535.03
Total Value
$60.46K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
630
Price
$534.39
Total Value
$336.67K
Shares Held After
324,556
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,818
Price
$533.20
Total Value
$969.36K
Shares Held After
325,186
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,719
Price
$532.27
Total Value
$1.45M
Shares Held After
327,004
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,115
Price
$531.10
Total Value
$592.18K
Shares Held After
329,723
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,285
Price
$530.45
Total Value
$1.21M
Shares Held After
330,838
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
820
Price
$528.72
Total Value
$433.55K
Shares Held After
333,123
% of Holdings
0.2%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
1,100
Price
$12.88
Total Value
$14.17K
Shares Held After
5,607,702
% of Holdings
0.0%
Immunovant, Inc. (IMVT)
Pande Atul — Director
Shares
1,500
Price
$39.80
Total Value
$59.70K
Shares Held After
116,731
% of Holdings
1.3%
Shares
2,616
Price
$1.21
Total Value
$3.17K
Shares Held After
3,280,272
% of Holdings
0.1%
Olema Pharmaceuticals, Inc. (OLMA)
Harmon Cyrus — Director
Shares
12,500
Price
$11.58
Total Value
$144.74K
Shares Held After
715,270
% of Holdings
1.7%
Opus Genetics, Inc. (IRD)
Gagnon Robert E. — Chief Financial Officer
Shares
7,783
Price
$2.95
Total Value
$22.94K
Shares Held After
584,375
% of Holdings
1.3%
Opus Genetics, Inc. (IRD)
Magrath George — Director
Shares
9,475
Price
$2.95
Total Value
$27.93K
Shares Held After
1,731,869
% of Holdings
0.5%
Opus Genetics, Inc. (IRD)
YERXA BENJAMIN R — Director
Shares
7,429
Price
$2.97
Total Value
$22.06K
Shares Held After
704,106
% of Holdings
1.0%
Opus Genetics, Inc. (IRD)
SCHACHLE JOSEPH K — Chief Operating Officer
Shares
4,644
Price
$2.94
Total Value
$13.65K
Shares Held After
291,440
% of Holdings
1.6%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
2,500
Price
$13.14
Total Value
$32.85K
Shares Held After
5,606,602
% of Holdings
0.0%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
2,857
Price
$38.69
Total Value
$110.54K
Shares Held After
205,341
% of Holdings
1.4%
Immunovant, Inc. (IMVT)
Girao Tiago — Chief Financial Officer
Shares
6,798
Price
$38.69
Total Value
$263.01K
Shares Held After
240,798
% of Holdings
2.7%
INSMED Inc (INSM)
Lewis William — Director
Shares
5,872
Price
$106.43
Total Value
$624.96K
Shares Held After
259,058
% of Holdings
2.2%
INSMED Inc (INSM)
Lewis William — Director
Shares
4,828
Price
$105.62
Total Value
$509.93K
Shares Held After
264,930
% of Holdings
1.8%
Shares
54,760
Price
$1.30
Total Value
$71.30K
Shares Held After
3,282,888
% of Holdings
1.6%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
3,600
Price
$90.71
Total Value
$326.54K
Shares Held After
501,477
% of Holdings
0.7%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
96,400
Price
$89.44
Total Value
$8.62M
Shares Held After
505,077
% of Holdings
16.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$531.83
Total Value
$106.37K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,201
Price
$530.84
Total Value
$637.54K
Shares Held After
324,643
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,279
Price
$529.86
Total Value
$1.21M
Shares Held After
325,844
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,133
Price
$529.08
Total Value
$1.13M
Shares Held After
328,123
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,989
Price
$527.77
Total Value
$1.05M
Shares Held After
330,256
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
552
Price
$526.88
Total Value
$290.84K
Shares Held After
332,245
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
387
Price
$525.83
Total Value
$203.50K
Shares Held After
332,797
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
171
Price
$524.86
Total Value
$89.75K
Shares Held After
333,184
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
339
Price
$523.72
Total Value
$177.54K
Shares Held After
333,355
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
249
Price
$522.87
Total Value
$130.19K
Shares Held After
333,694
% of Holdings
0.1%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
59,880
Price
$9.96
Total Value
$596.40K
Shares Held After
17,242,483
% of Holdings
0.3%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
162,500
Price
$21.25
Total Value
$3.45M
Shares Held After
574,047
% of Holdings
22.1%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
162,500
Price
$21.25
Total Value
$3.45M
Shares Held After
574,054
% of Holdings
22.1%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
1,669
Price
$325.00
Total Value
$542.42K
Shares Held After
0
% of Holdings
100.0%
Shares
38,016
Price
$1.33
Total Value
$50.48K
Shares Held After
3,337,648
% of Holdings
1.1%
Intellia Therapeutics, Inc. (NTLA)
Dulac Edward J III — EVP, Chief Financial Officer
Shares
8,111
Price
$11.25
Total Value
$91.25K
Shares Held After
148,175
% of Holdings
5.2%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
14,562
Price
$89.24
Total Value
$1.30M
Shares Held After
601,477
% of Holdings
2.4%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
48,032
Price
$88.65
Total Value
$4.26M
Shares Held After
616,039
% of Holdings
7.2%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
37,406
Price
$87.70
Total Value
$3.28M
Shares Held After
664,071
% of Holdings
5.3%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
84,124
Price
$9.93
Total Value
$835.35K
Shares Held After
17,182,603
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$539.47
Total Value
$43.16K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$538.46
Total Value
$366.15K
Shares Held After
324,523
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
570
Price
$537.60
Total Value
$306.43K
Shares Held After
325,203
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
790
Price
$536.49
Total Value
$423.83K
Shares Held After
325,773
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
107
Price
$535.40
Total Value
$57.29K
Shares Held After
326,563
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
324
Price
$534.18
Total Value
$173.08K
Shares Held After
326,670
% of Holdings
0.1%
Showing 101–150 of 3467 transactions (page 3 of 70)